A San Francisco company has developed a software package that “stitches” digital radiographs together in the same way a series of photographs are combined to create a panorama.Several original equipment manufacturers and distributors are
A San Francisco company has developed a software package that “stitches” digital radiographs together in the same way a series of photographs are combined to create a panorama.
Several original equipment manufacturers and distributors are evaluating the AccuStitch package, developed by AccuImage. The company hopes to begin marketing the product once the distribution methodology has been finalized, probably this month. Because the original images are bundled with the stitched image, no FDA action is required before the company can begin selling the product, said Leon Kaufman, Ph.D., AccuImage CEO.
”We’ve been around the imaging business a long time, and it didn’t seem too difficult to create a package that was very specific to this need and would allow users not only to do this easily and accurately, but also to validate that they were doing it properly,” Kaufman said.
The company has filed for a patent covering the technology. A firm price for the product has not been set, Kaufman said. It could find a place in angiography, but it might be particularly useful in orthopedic applications, in which long portions of the body, such as bones or the spinal column, are imaged, he said.
Because most radiography systems cover only a limited area of the body, images of these long segments must be combined. Until now, that was usually done by placing the images side by side on a viewbox or by using photographic software that was not specific for medical applications.
With AccuStitch, landmarks are created on each image, which are either acquired digitally or digitized after film capture. The program matches the landmarks to line up the images lengthwise, laterally, and rotationally. The software also gives users flexibility in adjusting and blending the images.
”Stitching now is very crude,” Kaufman said. “What’s been available in this market has not been very creative.”
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.